![]() |
|
|
Departments of 4 Clinical Immunology and Biochemical Genetics and 5 Cardiology, Royal Perth Hospital; Perth, Australia 6000; Schools of 6 Surgery and Pathology and 7 Medicine and Pharmacology, University of Western Australia, Nedlands, Australia 6009; 8 Centre for Clinical Immunology and Biomedical Statistics, Murdoch University and Royal Perth Hospital, Perth, Australia 6000; and 9 School of Biomedical Sciences, Curtin University of Technology, Bentley, Australia 6102
* To whom correspondence should be addressed. E-mail: c.mamotte{at}curtin.edu.au.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The role of the above 3 genes in lipid metabolism needs no further emphasis at this point, but study of the LRP exon 22 C200T polymorphism requires further explanation. It is relevant because we recently showed the presence of the C allele and C homozygosity to have a strong association with premature CAD (5) and Schulz et al. (6) reported the C200T polymorphism is part of an LRP haplotype, consisting of several loci in disequilibrium, which was also associated with myocardial infarction. Many polymorphisms have been identified in the LRP gene (7), but of 7 exonic polymorphisms we previously studied (5), this particular polymorphism showed the clearest relation with CAD. The association in both males and females (5), and the study by Schulz et al. (6), support the validity of the relation although the basis for it remains unclear, especially because the C200T polymorphism, although exonic, does not result in an amino acid change. LRP is a member of the LDLR gene family, with diverse ligands involved in vascular physiology (8) and playing a particular role in chylomicron (CM) remnant (CR) clearance (9–11). We did not find an unequivocal influence of the polymorphism on fasting plasma lipid concentrations (5). However, in view of the role of LRP in the clearance of CR, lipoproteins that are considered by many to have an important role in the pathogenesis of CAD (12–14), it seemed plausible that the polymorphism may be associated with a postprandial increase in CR following a fatty meal. For example, the CC genotype might delay the clearance of CR compared with that associated with the TT genotype, leading to higher postprandial concentrations in the C homozygotes. Hence, subjects homozygous for the C and T alleles of the LRP exon 22 polymorphism were selected for the study.
This study can, therefore, be considered to encompass several novel aims: to determine the effect, over a 10-h period, of a single high-fat meal on the expression of the genes for LDLR, LRP, and HMGCR in circulating mononuclear cells; to assess any effect of the LRP exon 22 C200T polymorphism on plasma lipids immediately following the meal; and, implicitly, to examine the influence of the polymorphism on the expression of the target genes.
| Materials and Methods |
|---|
|
|
|---|
We studied 20 male subjects, selected from those previously described (5), without evidence of CAD, on the basis of genotype, age-matching, and availability. Twelve were homozygous for the C and 8 for the T allele of the LRP exon 22 polymorphism. Ten of the CC subjects had the apolipoprotein (apo) E3/E3 genotype and 2 were E3/E2; 7 of the TT subjects were apo E3/E3 and 1 was apo E3/E2. The Ethics Committee of Royal Perth Hospital approved the study protocol and all subjects gave their informed consent.
Subjects abstained from alcohol for 48 h and fasted for 12 h. After obtaining fasting blood samples, they ingested, within 5 min, a high-fat load in the form of a milkshake and 2 capsules containing 105 µmol (equivalent to 100,000 IU) vitamin A as retinyl palmitate (RP; Retinol, Janssen-Cilag). The milkshake was prepared as described by Parhofer et al. (15) and consisted of 100 mL dairy milk (3.5% fat), 150 mL cream (30% fat), 70 mL corn oil, 90 g egg, 10 g sugar, and 3.5 g coffee flavoring. This fatty drink yielded 5460 kJ, 87% from fat, 7% from carbohydrates, and 6% from protein. Overall, the meal contained
340 mg of cholesterol and 120 g of fat, with a SFA:PUFA:monounsaturated fatty acid ratio of 38:45:35. Blood samples were collected after 1, 2, 4, 6, 8, and 10 h, during which subjects were allowed no food or drink, other than water, and could walk but not exercise more vigorously.
Blood was drawn into sterile tubes (Vacutainer, Becton Dickinson) containing Na2EDTA. All tubes were promptly processed, with minimum exposure to light, by centrifugation (1700 x g; 10 min at 4°C). The buffy coat layer was collected for preservation of RNA and the plasma was pooled; 2 mL was used for measurement of total cholesterol (TC), HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), triglyceride (TG), and RP, and 5 mL for isolation of lipoprotein fractions by ultracentrifugation. Aliquots of plasma for RP measurement were stored at –80°C and wrapped in foil prior to analysis.
Lipoprotein separation
Two TG-rich lipoprotein fractions were isolated from plasma by ultracentrifugation: a Svedberg flotation (Sf) > 400 fraction, containing CM, and a Sf 20 – 400 fraction containing smaller TG-rich lipoproteins, including intestinally derived CR and the hepatic-derived VLDL and VLDL remnants. Plasma in a 6.5-mL Quick-Seal tube (Beckman Coulter) was overlaid with a solution of potassium bromide of 1.006 kg/L density and then heat-sealed. The tubes were centrifuged at 28,000 x g; 20°C for 30 min using an 80Ti rotor in a Beckman ultracentrifuge (Model L8–70M) to float CM particles (Sf > 400). The CM fraction was removed from the top 1 mL of the supernatant using a tube slicer (Fisher Biotec). The infranatant was overlaid with a potassium bromide solution of 1.006 kg/L density and the CR + VLDL (Sf 20–400) fraction isolated by ultracentrifugation (80Ti rotor, 112,000 x g; 20°C for 18 h). One milliliter of the CR + VLDL containing supernatant was collected. Tubes were stored wrapped in foil at –80°C.
Lipid assays
Plasma samples were assayed for TC, HDL-C, LDL-C, and TG, while CM and CR + VLDL fractions were assayed for TC, TG, and RP. TC, HDL-C, and TG concentrations were determined by enzymatic methods using Roche Diagnostics reagents on a Hitachi 917 analyzer. LDL-C concentrations were measured using a Direct LDL-C assay (Boehringer Mannheim) on the same instrument.
RP extraction and analysis
RP concentrations were determined by HPLC as described by Parhofer et al. (15), using retinyl acetate as an internal standard. Plasma, CM, and CR + VLDL fractions from any 1 subject were extracted and analyzed in the 1 analytical run.
mRNA quantification
RNA isolation. Duplicate samples of total RNA were preserved in Ultraspec reagent (Fisher Biotec). Briefly, they were extracted by a guanidinium thiocyanate-phenol-chloroform method. RNA pellets were washed twice with 75% ethanol (analytical grade, in diethylpyrocarbonate-treated water), suspended in RNase-free water (Qiagen), and stored at –70 to –80°C. The quantity and purity of the extracted RNA were assessed spectrophotometrically by examination at 260, 280, 270, 230, and 320 nm. RNA integrity was also assessed by electrophoresis on an agarose gel. The yield of RNA from 278 samples was 21.0 ± 0.4 µg (mean ± SEM).
cDNA synthesis and quantitation. An aliquot (1 µg) of RNA was used for each reverse-transcription reaction. The RNA was denatured at 65°C for 5 min, cooled on ice, and added to a reaction mixture containing 2 µL of 500 mg/L oligo(dT)15 primer (Promega), 2 µL of a 5 mmol/L deoxynucleoside triphosphate (dNTP) solution (1.25 mmol/L of each dNTP, Invitrogen), 2 µL of 10x RT buffer (Qiagen), 0.3 µL of 40 MU/L RNAsin (Invitrogen), and 1 µL of 4.5 MU/L Omniscript RT (Qiagen) in a total volume of 20 µL. The cDNA synthesis was performed in a Perkin Elmer Cetus DNA Thermal Cycler and was comprised of a 60-min incubation at 37°C and terminated by chilling to 4°C for 5 min.
A 5-µL aliquot of a 10-fold dilution of the cDNA was used for real-time quantitative PCR for all genes examined. This was added to 0.1-mL PCR strip tubes (Fisher Biotec) containing a 15 µL mix comprising: 2 µL of 10x PCR buffer (100 mmol/L Tris-HCl, pH 8.3, 500 mmol/L KCl, 0.1 g/L gelatin), 1.2 µL of 25 mmol/L MgCl2, 1 µL of 25 g/L bovine serum albumin, 1 µL of dNTP mix (final concentration 200 µmol/L for each dNTP), 1 µL of each PCR primer (final concentration 0.5 µmol/L), 0.2 µL of 5 MU/L Platinum Taq DNA polymerase, and 2 µL of a 5x concentration of SYBR Green I (Sigma). The PCR were carried out in real-time mode on a Rotor-Gene 3000 (Corbett Research) thermocycler. The temperature program for PCR was as follows: 1 cycle of 95°C for 5 min, 35–40 cycles of 95°C for 10 s; 64°C for 15 s; and 72°C for 25 s. Fluorescence was measured after the extension step of each cycle at 72°C. The sequence of the primers used for amplification of the cDNA is documented in Supplemental Table 1.
Statistical analyses
Trends over time in the lipid and mRNA responses, and differences between the 2 genotypes, were tested using multiple linear mixed regression (on the log scale) with quadratic or cubic mixed models using SPlus (Insightful). The models incorporated adjustment for both BMI and apo E genotype. Where these comparisons indicated a significant response with time, or between genotypes, comparisons at specific time points were carried out using paired (for comparisons with baseline) or unpaired (between genotypes) t tests. Except where otherwise indicated, values in the text are means ± SEM and differences with P < 0.05 were considered significant. All lipid and mRNA data were log transformed prior to statistical analyses.
| Results |
|---|
|
|
|---|
|
2 times the baseline fasting concentration and remained elevated for a further 4 h. In contrast, plasma LDL-C and HDL-C decreased from baseline for the 2–8-h and 4–8-h time intervals, respectively (Table 2). Although the 2 genotype subgroups did not differ in plasma HDL-C, TG, or TC concentrations, C homozygotes had a significantly smaller decrease in plasma LDL-C postprandially than T homozygotes (Table 2).
|
3–4 times the baseline value in the middle of the observation period (Supplemental Table 2). The changes in TG and cholesterol in the CR + VLDL fraction were small but significant (Supplemental Table 2). RP concentrations in plasma, CM, and CR + VLDL fractions increased significantly at 1 h and remained elevated above the baseline level for the remainder of the observation period (Supplemental Table 3). The RP concentration in plasma, and in the CM, and CR + VLDL fractions were not significantly different between CC and TT subjects (0.25 < P < 0.4). The TG and cholesterol concentrations of the CM and CR + VLDL fractions also did not differ between the genotype groups. LRP, LDLR, and HMGCR mRNA in mononuclear blood cells. We examined the data on LDLR, LRP, and HMGCR mRNA in 2 ways: the total or raw mRNA abundance and their abundance relative to a housekeeping or reference gene [ß-actin (BA)]. The latter is the more common method of expression in the literature, but, in general, the results of the 2 approaches were consistent. Results for the mRNA studies were not available for 2 subjects, a C and a T homozygote, due to excessive RNA degradation during the isolation procedure.
In response to the fat meal, LDLR and LRP mRNA expression decreased without change in HMGCR mRNA expression (Table 3). There was a significant postprandial decrease in LDLR relative to BA mRNA (LDLR/BA) apparent as early as 1 h. Collectively, the lowest level attained, a 25% decrease compared with the baseline value, occurred 6 h postprandially. The raw mRNA LDLR data showed similar behavior, also reaching a nadir, corresponding to a 21% decrease, 6 h postprandially.
|
Raw LDLR mRNA abundance tended to be greater in CC subjects than in TT subjects (P = 0.15), whereas the LDLR/BA was significantly higher in CC subjects at baseline and for the entire study period (Table 3). Whereas CC subjects had a significantly higher LDLR mRNA expression, the postprandial changes in LDLR mRNA did not differ between the 2 genotype subgroups. For example, the nadir in LDLR/BA occurred at the 6-h time point in both groups and was of similar magnitude, representing decreases of 26% and 25% in CC and TT subjects, respectively. The CC and TT subjects did not differ in LRP mRNA or LRP/BA expression (Table 3).
Finally, and in contrast to results on LDLR and LRP mRNA, there was no evidence of any changes in HMGCR mRNA expression over the postprandial period nor of any LRP genotype effect (not shown).
| Discussion |
|---|
|
|
|---|
Although the results on the mRNA of the target genes proved to be of greater interest, the influence of the LRP polymorphism on postprandial lipoprotein metabolism will be discussed first.
Influence of the LRP polymorphism on postprandial lipids. Because of the association of the LRP C200T polymorphism with premature CAD and the role of LRP in the clearance of CR, we considered it plausible that the polymorphism may be associated with delayed clearance of CR in the postprandial period. In examining C and T homozygotes, we also took account of variables that might influence postprandial lipoprotein clearance. All subjects were male Caucasians, within a small age range, abstained from alcohol for 48 h, and consumed a normal western diet. Apo E polymorphisms, including the E2 and E4 alleles, reportedly affect postprandial lipoprotein metabolism (16–21). Their possible influence was considered by using multivariate mixed models for adjustment.
Dietary fat is assembled into TG-rich CM and secreted into the circulation before hydrolysis by lipoprotein lipase to CR (22). Because it is difficult to separate CM and CR from VLDL and VLDL remnants, studies examining postprandial changes in CM and CR often use retinol or RP as a marker for these intestinally derived lipoproteins. Following absorption, RP is secreted from the intestine as a component of CM and largely remains with the particles as they are metabolized to CR. RP is therefore considered a better marker for CM and CR than plasma TG, which also reflects liver-produced VLDL and VLDL remnants (23). However, the concentrations of RP, in plasma as well as in CM and CR + VLDL fractions, were not significantly higher in CC than TT subjects. Nevertheless, the data do not completely exclude a difference in CM and CR clearance between the 2 LRP genotype subgroups, because the high degree of between-individual variation limited statistical power. On the other hand, we observed a smaller postprandial decrease in plasma LDL-C in C homozygotes.
mRNA studies: influence of the high-fat meal. The mRNA of the target genes was measured in human mononuclear cells, which have also been examined in more prolonged dietary studies (3,4,24). It is relevant that the expression of LDLR and HMGCR mRNA in the general population of circulating mononuclear cells from normal subjects correlated with that of the corresponding mRNA in the liver (25). As for liver cells, the synthesis of sterols in mononuclear cells was found to depend on HMGCR activity (26), and the binding of LDL, reflecting LDLR activity, was upregulated by incubation in lipoprotein-deficient medium (27). It therefore appears that, in humans, the coordinate regulation of HMGCR and of LDLR is similar in liver and mononuclear cells, the latter being more accessible for studies on human subjects.
Our results indicate that LDLR mRNA expression decreased in both LRP genotype subgroups during the postprandial period. To our knowledge, no other studies have examined the immediate effect on gene expression of an acute dietary intervention in man, although the influence of a change in diet has been studied. Vidon et al. (4) found a 3-wk high-fat diet had little influence on the LDLR mRNA of peripheral mononuclear cells. In contrast, Boucher et al. (3) found that the LDLR mRNA expression of circulating mononuclear cells in men increased in response to 4 d of consuming a low-cholesterol, low-fat diet and decreased when the fat-restricted diet was supplemented with cholesterol. The present study has considerably extended that observation. Our finding is analogous to the early observation on human mononuclear cells, in vitro, of a similarly timed, decreased expression of LDLR mRNA upon exposure to LDL (2). However, it is noteworthy that, in our study, the postprandial increases in plasma TC and CM cholesterol were small, whereas LDL-C decreased slightly. The decreased LDLR mRNA was, presumably, due to an intracellular effect subsequent to the influx of dietary fat or cholesterol. Further studies to elucidate the precise mechanism underlying these mRNA changes are required, but investigations in other species have found clear evidence that LDL-receptor expression can be influenced not only by cholesterol but also by fatty acids (28,29); PUFA and SFA having opposite effects.
The trend for lower LRP mRNA expression became significant during the later part of the postprandial period. There are no other comparable studies, to our knowledge, but Vidon et al. (4) reported LRP mRNA in circulating mononuclear cells to be higher in subjects who consumed a high-fat diet for 3 wk compared with an isocaloric high-carbohydrate diet, while Boucher et al. (3) reported a decrease in response to 4 d of consuming a low-cholesterol, low-fat diet and an increase after reintroduction of cholesterol to the diet. The acute response we found is contrary to these observations, (3,4) but, whereas little is known of the regulation of the LRP gene, the concordant behavior of LDLR and LRP mRNA in our study indicates that the immediate regulation of the 2 genes, in response to a fat load, are directionally similar, and supports previous suggestions that the roles of these 2 receptors in lipoprotein uptake by cells may be complementary (9–11).
The mRNA for HMGCR was unaffected by consumption of the fat meal. In contrast, Vidon et al. (4) found HMGCR mRNA expression in mononuclear cells was lower in subjects consuming a high-fat diet for 3 wk compared with those consuming a high-carbohydrate diet; Boucher et al. (3) found the expression was higher in subjects consuming a diet low in cholesterol and fat and decreased when the fat-restricted diet was supplemented with cholesterol. Those findings are consistent with the coordinate regulation of HMGCR and LDLR genes by cholesterol (1) and with the mRNA expression of HMGCR and LDLR in mononuclear leukocytes generally being directly correlated (25). One other study in men found that HMGCR enzyme activity in mononuclear cells decreased within 2 h of a single high-cholesterol meal (24). Unless this different result relates to the nature of the meal, reconciliation of this finding on enzyme activity with our mRNA result would imply that other aspects of HMGCR regulation precede the change in HMGCR mRNA expression in response to an acute fat load. In any case, we observed suppression of LDLR and LRP mRNA expression when there was no effect on HMGCR mRNA.
mRNA studies: influence of LRP genotype. Broadly, the mRNA data indicated that subjects with the CC genotype had a higher expression of LDLR mRNA in mononuclear cells than did TT subjects. On the other hand, the postprandial changes in the mRNA did not differ between these 2 genotype subgroups. It is presently unclear why the LRP gene polymorphism should influence LDLR gene expression, but there is evidence that the roles of LDLR and LRP are coordinated in the cellular binding and uptake of remnant particles (9–11). One possibility is that inheritance of the C allele is associated with diminished LRP function and results in a compensatory increase in the expression of LDLR. There is no other information available concerning the function of LRP resulting from the C200T polymorphism. However, it should be noted that the polymorphism does not result in an amino acid substitution; the influence of the polymorphism is therefore most likely due to linkage to other more functional polymorphisms in the LRP gene. Finally, although we did not substantiate defective remnant clearance in CC subjects, it may be that any defect was partly compensated by the increase in LDLR gene expression.
This study provided novel evidence of an early decrease in LDLR mRNA in men and a later decrease in LRP mRNA in circulating mononuclear cells during the postprandial period. The relatively rapid change in LDLR mRNA expression is consistent with several longer term dietary intervention studies and more basic observations on the regulation of LDLR gene expression by lipids. Less is known about the regulation of the LRP gene. The postprandial decrease in LRP mRNA is contrary to the results of the few dietary studies available but consistent with coordinate regulation of the LDLR and LRP genes. There was no clear effect of the LRP exon 22 C200T polymorphism on most plasma lipids postprandially, but, compared with their T homozygote counterparts, C homozygotes had a smaller decrease in plasma LDL-C concentrations. The higher LDLR mRNA expression in C homozygotes may represent partial compensation for defective LRP function.
| FOOTNOTES |
|---|
2 Author disclosures: A. Pocathikorn, R. R. Taylor, I. James, and C. D. S. Mamotte, no conflicts of interest. ![]()
3 Supplemental Tables 1–3 are available with the online posting of this paper at jn.nutrition.org. ![]()
10 Abbreviations used: apo, apolipoprotein; BA, ß-actin; CAD, coronary artery disease; CM, chylomicron; CR, chylomicron remnant; dNTP, deoxynucleoside triphosphate; HDL-C, HDL cholesterol; HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase; LDL-C, LDL cholesterol; LDLR, LDL receptor; LRP, LDL receptor-related protein; mRNA, messenger RNA; RP, retinyl palmitate; Sf, Svedberg flotation; TC, total cholesterol; TG, triglyceride. ![]()
Manuscript received 20 March 2007. Initial review completed 7 April 2007. Revision accepted 2 July 2007.
| LITERATURE CITED |
|---|
|
|
|---|
1. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34–47.
2. Cuthbert JA, Russell DW, Lipsky PE. Regulation of low density lipoprotein receptor gene expression in human lymphocytes. J Biol Chem. 1989;264:1298–304.
3. Boucher P, de Lorgeril M, Salen P, Crozier P, Delaye J, Vallon JJ, Geyssant A, Dante R. Effect of dietary cholesterol on low density lipoprotein-receptor, 3-hydroxy-3-methylglutaryl-CoA reductase, and low density lipoprotein receptor-related protein mRNA expression in healthy humans. Lipids. 1998;33:1177–86.[Medline]
4. Vidon C, Boucher P, Cachefo A, Peroni O, Diraison F, Beylot M. Effects of isoenergetic high-carbohydrate compared with high-fat diets on human cholesterol synthesis and expression of key regulatory genes of cholesterol metabolism. Am J Clin Nutr. 2001;73:878–84.
5. Pocathikorn A, Granath B, Thiry E, Van Leuven F, Taylor R, Mamotte C. Influence of exonic polymorphisms in the gene for LDL receptor-related protein (LRP) on risk of coronary artery disease. Atherosclerosis. 2003;168:115–21.[Medline]
6. Schulz S, Schagdarsurengin U, Greiser P, Birkenmeier G, Muller-Werdan U, Hagemann M, Riemann D, Werdan K, Glaser C. The LDL receptor-related protein (LRP1/A2MR) and coronary atherosclerosis: novel genomic variants and functional consequences. Hum Mutat. 2002;20:404.[Medline]
7. Van Leuven F, Stas L, Thiry E, Nelissen B, Miyake Y. Strategy to sequence the 89 exons of the human LRP1 gene coding for the lipoprotein receptor related protein: identification of one expressed mutation among 48 polymorphisms. Genomics. 1998;52:138–44.Erratum in: Genomics 1999;58:111.[Medline]
8. Strickland DK, Kounnas MZ, Argraves WS. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 1995;9:890–8.[Abstract]
9. Cooper AD. Hepatic uptake of chylomicron remnants. J Lipid Res. 1997;38:2173–92.[Abstract]
10. Mahley RW, Ji Z-S. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res. 1999;40:1–16.
11. Martins IJ, Hone E, Chi C, Seydel U, Martins RN, Redgrave TG. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice. J Lipid Res. 2000;41:205–13.
12. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb. 1991;11:653–62.
13. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 1992;12:1336–45.
14. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60:473–85.
15. Parhofer KG, Barrett PHR, Schwandt P. Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects. J Clin Endocrinol Metab. 2000;85:4224–30.
16. Mamotte CD, Burke V, Taylor RR, van Bockxmeer FM. Evidence of reduced coronary artery disease risk for apolipoprotein epsilon2/3 heterozygotes. Eur J Intern Med. 2002;13:250–5.[Medline]
17. Bergeron N, Havel RJ. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. J Clin Invest. 1996;97:65–72.[Medline]
18. Brown AJ, Roberts DC. The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arterioscler Thromb. 1991;11:1737–44.
19. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest. 1987;80:1571–7.[Medline]
20. Brenninkmeijer BJ, Stuyt PM, Demacker PN, Stalenhoef AF, van 't Laar A. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype. J Lipid Res. 1987;28:361–70.[Abstract]
21. Orth M, Wahl S, Hanisch M, Friedrich I, Wieland H, Luley C. Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype. Biochim Biophys Acta. 1996;1303:22–30.[Medline]
22. Cohn JS, Johnson EJ, Millar JS, Cohn SD, Milne RW, Marcel YL, Russell RM, Schaefer EJ. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res. 1993;34:2033–40.[Abstract]
23. Griffin BA, Fielding BA. Postprandial lipid handling. Curr Opin Clin Nutr Metab Care. 2001;4:93–8.[Medline]
24. Harwood HJ Jr, Bridge DM, Stacpoole PW. In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Studies in normal subjects. J Clin Invest. 1987;79:1125–32.[Medline]
25. Powell EE, Kroon PA. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver. J Clin Invest. 1994;93:2168–74.[Medline]
26. Fogelman AM, Edmond J, Polito A, Popjak G. Control of lipid metabolism in human leukocytes. J Biol Chem. 1973;248:6828–9.
27. Ho YK, Brown S, Bilheimer DW, Goldstein JL. Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes. J Clin Invest. 1976;58:1465–74.[Medline]
28. Fernandez ML, West KL. Mechanisms by which dietary fatty acids modulate plasma lipids. J Nutr. 2005;135:2075–8.
29. Mustad VA, Ellsworth JL, Cooper AD, Kris-Etherton PM, Etherton TD. Dietary linoleic acid increases and palmitic acid decreases hepatic LDL receptor protein and mRNA abundance in young pigs. J Lipid Res. 1996;37:2310–23.[Abstract]
This article has been cited by other articles:
![]() |
P. L.S.M. Gordts, S. Reekmans, A. Lauwers, A. Van Dongen, L. Verbeek, and A. J.M. Roebroek Inactivation of the LRP1 Intracellular NPxYxxL Motif in LDLR-Deficient Mice Enhances Postprandial Dyslipidemia and Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1258 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Bruder, J. K. Taylor, K. J. Kamer, and H. Raff Development of the ACTH and corticosterone response to acute hypoxia in the neonatal rat Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1195 - R1203. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||